GenAI: 9 proof points
Rows on the facts page whose own text or source section carries "GenAI". The product name links the page with the full text. All skills.
| Role | Product | Situation | Task | Action | Result | Year | Skills |
|---|---|---|---|---|---|---|---|
| Associate Product Director at Novo Nordisk | GenAI proof of concept for automating compliance reviews Agentic RAG proof of concept for compliance reviews, with a Figma plugin | Every release of health software needed sign-off from medical, legal and regulatory reviewers. The process was built for marketing materials, not software: every screen was manually captured as a PDF and reviewed manually, stacking the regulatory risk to the end of the development cycle and sometimes adding months to delivery. | Test whether an LLM could take on the review so product teams could shift left: fail in design, not at review. Two acceptance tests set up front: useful to product teams, and catches what the manual review catches. | Used an internal LLM sandbox to build a RAG model of the guidelines and regulations, producing a full audit trail per submission. Built a prototype agent that plugged into Figma so designers could query the guidelines before investing effort. Pitched it to senior leadership & tested with product team. | Product team loved it. The proof of concept showed a clear path to much faster release cycles, but the timing was 12 months too early & the business was not ready for AI. Tom moved to help the Wegovy Pill launch. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, discovery, prototyping, ways of working, launch, marketing, team leadership, stakeholders |
| Associate Product Director at Novo Nordisk | CagriSema Digital discovery programme for CagriSema, the company's top drug asset | CagriSema was the first drug to span two therapy areas, diabetes and obesity. Each business unit ran independently with their own priorities and budgets. | Define what digital initiatives should accompany the drug, get both business units to agree, and get it funded. | Started with the problem, and uncovering the new user journeys to create a shared understanding of the problem space across both units. Then ideation: 128 candidate ideas, cut to a shortlist of 5, assumption-tested with prototypes, 4 recommended, each with a funding-gated rollout. Navigated the programme through internal governance. | Funding secured for a portfolio of 4 digital initiatives (a first). Aligned two business units on a common digital strategy (also a first). | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, prototyping, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Digital Incubation Digital incubation unit for branded digital engagement, evaluating build, buy and partner solutions | Asked after Wegovycare to scale its ways of working across the product organisation: to work across silos and help move the organisation from solution-first project thinking to a product model with an outcomes focus. | Build the unit that shapes the organisation's next big bets, and make problem-first the default. | Built the incubation unit entirely through influence. Designed a portfolio model and a gated incubation pipeline. Wrote the discovery playbook. Coached the incubation PMs. Secured funding and managed resourcing and cross-charges for the incubation teams. Evaluated build, buy and partner options for each bet. | Moved the business from solution-first to problem-first, and from output to outcomes. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Product Operations standards, artefacts, ways of working | A wider remit across the product pipeline, to complete the move to a product operating model. | Establish metrics across a portfolio of 12 products. | Set product artefacts and quality standards: gate model and deliverables, product-ops metrics, portfolio reports, business case templates, problem and north-star statements. | Helped product teams connect work to commercial outcomes. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | Head of Patient Products Patient Solutions, a portfolio of consumer engagement products (companion apps adjacent to the medicines) | Interim reorg of product teams before the Wegovy Pill project. | Lead 6 experienced PMs building consumer engagement products, managing by outcomes; for a period, before moving into the pill team where the need was greatest. | Individual coaching and weekly experiment sharing; made individual product metrics public. | Broke product silos, established weekly demos and experiment sharing, encouraged learning loops. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Associate Product Director at Novo Nordisk | project steercos Chaired project steercos. Flipped the format from status updates to interactive co-creation | Steercos were project management checklists: project not product focused, and unsuited for high-uncertainty discovery-stage products. | Chair project steercos. | Flipped the format from status updates to interactive co-creation. | Cross-functional VPs moved from product sceptics to advocates. | Feb 2022 - Feb 2026 | AI, GenAI, regulated, compliance, pharma, healthcare, patients, discovery, incubation, ways of working, growth, retention, funnels, experimentation, launch, brand, team leadership, stakeholders, consumer, budget |
| Solo projects, building with AI | TomBot TomBot, a chatbot CV at takenbyninjas.com | Tom wanted to create a novel way of presenting his CV, and find out first-hand what AI can and cannot do. Accuracy of recall was the key criterion: a CV bot that hallucinates is worse than no bot. | Build something real with AI and ship it, in his own content and voice. | Built with Claude Code on the Claude API: chunked RAG vector store, eval suite, guard-rails. Question-to-question matching against a bank of pre-mapped questions rather than searching raw content: it limits the chatbot nature but keeps the answers accurate. Content and tone of voice his own. | Live January 2026. Linked from every CV with a UTM tag per employer so each application's traffic is visible. Pinned on LinkedIn. | 2026 | AI, GenAI, regulated, compliance, prototyping, team leadership |
| Solo projects, building with AI | kittenpm.com kittenpm.com, a free browser-based product management training SIM inspired by Lemmings | Wanted a portfolio piece that is not a portfolio, aimed at product peers and recruiters. | Generate reach and demonstrate product skills by teaching product trade-offs as a game. | Built with React, TypeScript and Phaser, using Claude as the engineering team. Players practise balancing product trade-offs in real time; those who complete the game get a digital certificate to embed on LinkedIn, which drives further reach. | Live July 2026, in public beta. | 2026 | AI, GenAI, regulated, compliance, prototyping, team leadership |
| Solo projects, building with AI | deathspiralorgoldenage.org deathspiralorgoldenage.org, a weekly public poll, live sentiment tracker and open economic model on AI's economic impact, with CC0 data | A thought experiment that spun out from a discussion at a Claude meetup with Anthropic. | Build a public, open-data way to track the question over time. | Researched and built with AI. Content is human; the site is engineered and researched with AI. Weekly poll, sentiment tracker and an open economic model, all data released CC0. | Live September 2026. | 2026 | AI, GenAI, regulated, compliance, prototyping, experimentation, team leadership |